BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28183848)

  • 21. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
    Her Z; Yong KSM; Paramasivam K; Tan WWS; Chan XY; Tan SY; Liu M; Fan Y; Linn YC; Hui KM; Surana U; Chen Q
    J Hematol Oncol; 2017 Oct; 10(1):162. PubMed ID: 28985760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment.
    Angelopoulou MK; Rinder H; Wang C; Burtness B; Cooper DL; Krause DS
    Transfusion; 2004 Apr; 44(4):555-66. PubMed ID: 15043572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
    Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
    Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.
    Shultz LD; Banuelos SJ; Leif J; Appel MC; Cunningham M; Ballen K; Burzenski L; Greiner DL
    Exp Hematol; 2003 Jun; 31(6):551-8. PubMed ID: 12829032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
    Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
    Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
    Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
    Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
    Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells.
    Krevvata M; Shan X; Zhou C; Dos Santos C; Habineza Ndikuyeze G; Secreto A; Glover J; Trotman W; Brake-Silla G; Nunez-Cruz S; Wertheim G; Ra HJ; Griffiths E; Papachristou C; Danet-Desnoyers G; Carroll M
    Haematologica; 2018 Jun; 103(6):959-971. PubMed ID: 29545344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.